Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $16.7400 (3.46%) ($16.2000 - $16.8200) on Tue. Apr. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 56 | Latest Price | $16.7400(3.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.1% a day on average for past five trading days. | Weekly Trend | HALO declines -0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(54%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting HALO price | HALO will decline at least -1.255% in a week (0% probabilities). VXX(-14%) UUP(-14%) VIXM(-5%) TLT(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 0 () | Intraday Trend | 3.3% | | | |
|
5 Day Moving Average | $16.11(3.91%) | 10 Day Moving Average | $16.07(4.17%) | 20 Day Moving Average | $16.07(4.17%) | To recent high | -4.8% | To recent low | 20.1% | Market Cap | $2.288b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |